Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

被引：585

作者：

Cappellen, D

De Oliveira, C

Ricol, D

de Medina, SGD

Bourdin, J

Sastre-Garau, X

Chopin, D

Thiery, JP

Radvanyi, F

机构：

[1] CNRS, Lab Morphogenese Cellulaire & Progress Tumorale, UMR 144, Inst Curie,Sect Rech, Paris 05, France

[2] Inst Curie, Med Sect, Dept Pathol, F-75248 Paris 05, France

[3] CHU Henri Mondor, Ctr Rech Chirurg, F-94010 Creteil, France

[4] CHU Henri Mondor, Serv Urol, F-94010 Creteil, France

来源：

NATURE GENETICS | 1999年 / 23卷 / 01期

关键词：

D O I：

10.1038/12615

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：18 / 20

页数：3

共 16 条

[1] The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts [J].

Chesi, M ;

Nardini, E ;

Lim, RSC ;

Smith, KD ;

Kuehl, WM ;

Bergsagel, PL .

BLOOD, 1998, 92 (09) :3025-3034

[2] Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 [J].

Chesi, M ;

Nardini, E ;

Brents, LA ;

Schrock, E ;

Ried, T ;

Kuehl, WM ;

Bergsagel, PL .

NATURE GENETICS, 1997, 16 (03) :260-264

[3] Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 [J].

Colvin, JS ;

Bohne, BA ;

Harding, GW ;

McEwen, DG ;

Ornitz, DM .

NATURE GENETICS, 1996, 12 (04) :390-397

[4] Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses [J].

Delezoide, AL ;

LasselinBenoist, C ;

LegeaiMallet, L ;

Brice, P ;

Senee, V ;

Yayon, A ;

Munnich, A ;

Vekemans, M ;

Bonaventure, J .

HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1899-1906

[5] Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas [J].

deMedina, SGD ;

Chopin, D ;

ElMarjou, A ;

Delouvee, A ;

LaRochelle, WJ ;

Hoznek, A ;

Abbou, C ;

Aaronson, SA ;

Thiery, JP ;

Radvanyi, F .

ONCOGENE, 1997, 14 (03) :323-330

[6] Fibroblast growth factor receptor 3 is a negative regulator of bone growth [J].

Deng, CX ;

WynshawBoris, A ;

Zhou, F ;

Kuo, A ;

Leder, P .

CELL, 1996, 84 (06) :911-921

[7] FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma [J].

Fracchiolla, NS ;

Luminari, S ;

Baldini, L ;

Lombardi, L ;

Maiolo, AT ;

Neri, A .

BLOOD, 1998, 92 (08) :2987-2989

[8] A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors [J].

Li, CL ;

Chen, L ;

Iwata, T ;

Kitagawa, M ;

Fu, XY ;

Deng, CX .

HUMAN MOLECULAR GENETICS, 1999, 8 (01) :35-44

[9]

MURGUE B, 1994, CANCER RES, V54, P5206

[10] Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia [J].

Naski, MC ;

Wang, Q ;

Xu, JS ;

Ornitz, DM .

NATURE GENETICS, 1996, 13 (02) :233-237

← 1 2 →